Cargando…

Review of bosentan in the management of pulmonary arterial hypertension

The dual endothelin receptor antagonist, bosentan, is an orally active therapy, which is effective in the treatment of pulmonary arterial hypertension (PAH). This review critically appraises the evidence for the efficacy of bosentan in idiopathic and familial PAH, in PAH associated with connective t...

Descripción completa

Detalles Bibliográficos
Autores principales: Gabbay, Eli, Fraser, John, McNeil, Keith
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2350123/
https://www.ncbi.nlm.nih.gov/pubmed/18200808